carbon monoxide and beraprost

carbon monoxide has been researched along with beraprost in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abe, M; Aoki, M; Hiranuma, M; Horie, T; Matsukawa, Y; Naruse, S; Nishinarita, S; Saito, O; Sawada, S	1

Trials

1 trial(s) available for carbon monoxide and beraprost

Article	Year
Long-term administration of beraprost, an oral prostacyclin analogue, improves pulmonary diffusion capacity in patients with systemic sclerosis. Prostaglandins, leukotrienes, and essential fatty acids, 2002, Volume: 67, Issue:1 Topics: Administration, Oral; Adult; Aged; Carbon Monoxide; Epoprostenol; Female; Humans; Lung; Male; Middle Aged; Pulmonary Diffusing Capacity; Scleroderma, Systemic; Time Factors	2002

Article

Year

Long-term administration of beraprost, an oral prostacyclin analogue, improves pulmonary diffusion capacity in patients with systemic sclerosis.

Prostaglandins, leukotrienes, and essential fatty acids, 2002, Volume: 67, Issue:1

Topics: Administration, Oral; Adult; Aged; Carbon Monoxide; Epoprostenol; Female; Humans; Lung; Male; Middle Aged; Pulmonary Diffusing Capacity; Scleroderma, Systemic; Time Factors

2002